Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you've taken your Mounjaro pen a day early, you're not alone. Taking tirzepatide every 6 days rather than every 7 comes up regularly, and the honest answer is short: the licensed schedule is once weekly, and that interval exists for clinical reasons rather than administrative convenience. That said, an occasional day's variation is not the same as routinely shifting your injection day, and understanding the difference matters. As a prescription-only medicine, how and when you take tirzepatide should always be guided by your prescriber and the Mounjaro Patient Information Leaflet on the eMC — this page explains the science behind the schedule so you can have a more informed conversation with them.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide's pharmacology is what sets the weekly interval. The molecule has a half-life of approximately five days, which means blood concentrations drop to around half their peak level over that period. A seven-day injection cycle keeps plasma levels within a steady therapeutic window: high enough after each dose to reduce appetite and slow gastric emptying, low enough by the following week that a new dose doesn't push concentrations into territory that drives unnecessary side effects.
This isn't guesswork. The SURMOUNT-1 trial, which tested tirzepatide in thousands of adults with obesity over 72 weeks and is one of the papers underpinning NICE's recommendation of tirzepatide (TA1026), used a strict once-weekly protocol throughout. The weight-loss outcomes (averaging around 20–21% body-weight reduction at the 15mg dose) were built on that schedule. Deviating from it means you're working outside the data.
The practical upshot: injecting every 6 days compresses the interval by roughly 14% each cycle. Over a month, that's nearly one extra dose's worth of exposure compared with the licensed schedule. For most people, an occasional day-early dose will not cause a crisis, but doing it consistently shifts the pharmacokinetic pattern the prescriber has built your titration plan around.
A question our prescribers hear most weeks is some version of: "I forgot which day I was on and took it on day 6, do I need to worry?" The short answer is usually no, provided it was a genuine one-off. The NHS tirzepatide page notes that if you take a dose early or late, you should return to your regular weekly day afterwards, not adjust the whole schedule forward.
The more relevant concern is side effects. Tirzepatide's most common adverse effects are gastrointestinal: nausea, loose stools, burping, reflux, and in some cases vomiting. These tend to be most pronounced in the first day or two after each injection, particularly after a dose increase. Shortening the interval to 6 days means the next dose arrives while GI sensitivity from the previous one may not have fully settled. For people who are already managing nausea carefully, that gap matters.
There's also the question of dose accuracy over time. If someone decides to routinely use a 6-day cycle rather than 7, they'll finish a pen earlier and need their next supply sooner. That can create practical problems, and it means clinical reviews, which inform every repeat at nume, are based on a different actual exposure pattern than the prescriber expects.
Shifting your injection day is a different situation from shortening the interval. If your usual day is Monday and you want to move to Thursday, that's a one-time adjustment: you take one injection slightly early or slightly late to bridge the gap, then settle into the new weekly rhythm. That's manageable and is exactly the kind of flexibility the NHS guidance on missed or displaced doses is designed to accommodate.
Running a deliberate 6-day cycle is something else. It means every injection comes slightly sooner than the previous one, there's no stable rhythm, and the cumulative drift adds up. A genuine desire to shift injection day should be discussed with your prescriber; they can advise on the safest way to make that move without disrupting your titration plan. Some people go further and ask whether taking Mounjaro every 5 days changes the clinical picture in any meaningful way, and our dedicated page explores exactly that. If you've been curious about what happens when people try taking Mounjaro every 5 days, our dedicated page covers the clinical picture in detail. Some people also ask about stretching the window; if budget is a factor, the cost context for Mounjaro in the UK and what transparent pricing actually covers is worth reading.
The short version: shifting your day once, with your prescriber's guidance, is fine. Building a permanent 6-day rhythm is not the same thing, and the medicine's safety and efficacy record doesn't apply to that schedule.
First, don't panic. If it's been occasional, the clinical significance is likely low. If it's been consistent over several weeks, the most useful step is to tell your prescriber at your next review, or contact them sooner if you've noticed a change in side effects or feel something is off.
At nume, every repeat order goes through a clinical review before dispatch. That's the right moment to raise a timing question: a GPhC-registered prescriber reviews your answers, can flag if your reported dose exposure looks unusual, and can advise on how to return to the licensed weekly schedule cleanly. If you have questions between reviews, our aftercare team is available seven days a week via the contact page.
The underlying principle is simple: tirzepatide is a prescription medicine with a licensed schedule that reflects real pharmacology and real trial data. The interval isn't arbitrary. If your circumstances have made that schedule genuinely difficult to stick to, whether you've been taking Mounjaro every 10 days to stretch supply or compressing the gap in the other direction, that's worth discussing openly with your prescriber rather than quietly adjusting around it. Check your eligibility and speak to our clinical team if you'd like that conversation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.